APA
IMUC

American Portfolios Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

American Portfolios Advisors’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5
Closed -$1 – 2648
2018
Q3 		$1 Hold
5
– – ﹤0.01% 2410
2018
Q2 		$1 Hold
5
– – ﹤0.01% 2378
2018
Q1 		$1 Hold
5
– – ﹤0.01% 2306
2017
Q4 		$2 Buy
+5
New +$2 ﹤0.01% 2259

Other funds holding IMUC

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

American Portfolios Advisors's IMUC Position: Q4 2018 in Review

American Portfolios Advisors sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2018, closing a stake of 5 shares — an estimated $1 sold.

American Portfolios Advisors first reported a position in IMUC in Q4 2017 and held it in 4 quarters. The position peaked at $2 in Q4 2017. 3 funds tracked by Wall St. Rank hold IMUC as of Q4 2018.

  • American Portfolios Advisors reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2018 after selling out during the quarter.
  • American Portfolios Advisors sold 5 ImmunoCellular Therapeutics, Ltd. shares in Q4 2018, an estimated $1.
  • American Portfolios Advisors first reported a position in ImmunoCellular Therapeutics, Ltd. in Q4 2017 and held it in 4 quarters.
  • American Portfolios Advisors's ImmunoCellular Therapeutics, Ltd. position peaked at $2 in Q4 2017.
  • 3 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2018.

Based on American Portfolios Advisors's 13F filing for Q4 2018, filed 24 Mar 2023.